A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Summary

Study to compare 2 different chemical forms of GSK1363089.

Timeline

Start

2008-08-11

Primary completion

2009-06-24

Completion

2009-06-24

Publications

• Background Naing A, Kurzrock R, Adams LM, Kleha JF, Laubscher KH, Bonate PL, Weller S, Fitzgerald C, Xu Y, LoRusso PM. A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. Invest New Drugs. 2012 Feb;30(1):327-34. doi: 10.1007/s10637-010-9536-x. Epub 2010 Sep 15.

Drugs

Indications